Purpose: To investigate the relationship between gross motor capacity and neuromuscular function in children with cerebral palsy (CP) through a short-term intensive intervention. Methods: Twenty-four children younger than 6 years of age (17 boys, 7 girls, mean age± standard deviation, 42.71±14.43 months) who were diagnosed with CP underwent short-term intensive treatment for 8 weeks. An evaluation of gross motor function capacity using the gross motor function measure (GMFM-66 and GMFM-88) was performed to measure muscle strength, selective motor control (SMC), and spasticity, factors related to neuromusculoskeletal function. Changes in spasticity, strength, range of motion, selective motor function, and exercise intensity scores were evaluated in terms of the gross motor function classification system (GMFCS) and ages. Results: The GMFM-88 and GMFM-66 scores significantly increased, by 4.32±4.04 and 2.41±1.51%, respectively, following the 8-week intervention. The change in the GMFM-66 score did not reflect a statistically significant difference in the GMFCS level. However, there was a statistically significant difference in the GMFM-88 score change in individuals at GMFCS Level III, the strength and spasticity of subjects at GMFCS Levels I-II did not significantly differ (p< 0.05). The changes in the GMFM-66 scores for strength, SMC, range of motion (ROM), and spasticity significantly differed according to age (p< 0.05) in children aged 36 months and older. Overall, there was a statistically significant difference in strength, SMC, and spasticity (p< 0.05) before and after intensive short-term treatment.
INTRODUCTION
Cerebral palsy (CP) is defined as a group of diseases with complex symptoms involving motor function, sensory perception, visual acuity, language, and cognitive impairment. 1 Disease severity depends primarily on the degree of damage to neuropsychiatric functions grounded in brain functioning. Loss or impairment of motor function is the most common problem in children with CP. The goal of CP treatment is to improve the exercise function through physical therapy involving strengthening the muscles, building endurance, and extending the range of motion (ROM). 2, 3 CP is a nonprogressive disorder caused by brain lesions; however, the ability to perform daily activities may be severely limited, affecting the quality of life of individuals with this disease.
Although problems associated with CP vary from child to child, there is a general perception of neuromuscular function impairment, such as spasticity, muscle weakness, ataxia, and loss of selective motor control (SMC). 4 In general, CP limits the movement of the limbs and trunk via abnormal muscle tension or lack of balance/ coordination, this occurs through the shortening of individual muscles or of a group of muscles in relation to the bones or joints, restricting free/voluntary coordinated movement. 5 Ballaz et al. 6 suggested that the ROM of the knee during bending, the bending motion, and the ankle joint motion are important kinematic factors 7 reported that the reduction in ROM is related to an increase in the activity limitations of children with a higher level of functional classification.
Another major factor is weakness, resulting from the state of constant tension of various muscle complexes. Recent studies have suggested the importance of strength training to improve the functional activity of children with CP. 8, 9 Thompson et al. 10 reported that additional muscular strength in the lower limbs improves walking ability.
SMC is performed by the central nervous system. At the functional level, SMC is one of the most important factors influencing activities involving large movements, such as device control and walking in children with CP. 11 Goldberg et al. 12 reported that walking ability is affected by SMC. Ostensjo et al. 13 showed that loss of SMC strongly affects behavior. Thus, functional activity is influenced by SMC.
Recently, the causal relationships among exercise injuries, activity, and the functional outcomes of children with CP were examined using path analysis, this study 14 showed a direct correlation between muscle strength and motor function in children with spastic CP, with abnormal muscle tone as a secondary factor. There have been numerous studies on SMC and large work function capability with respect to optimizing the range of joint motion. In a bilateral retrospective study, Ross et al. 15 reported on work function ability and strength improvement with spasticity reduction of the hip adductor of children with spastic CP. An understanding the effects of neuromuscular functional impairment on functional performance will be the basis for more effective treatment.
Therapeutic intervention in children with CP focuses on helping children perform tasks in a variety of settings. 16 The rehabilitation regimen of children with CP typically includes physical, neurological developmental, occupational, and speech therapies. 17 The effectiveness of rehabilitation is closely related to treatment concentration.
According to a recent meta-analysis, 18 intensive therapy is more effective than non-intensive treatment at the level of functional exercise. However, several short-term studies on the relationship between CP and intensive therapy indicated that this treatment approach is inadequate for improving the operating capacity, spasticity, strength, joint ROM, and neurological musculoskeletal elements of SMC. The purpose of this study was to investigate the relationship between gross motor capacity and neuromuscular function in children with CP by implementing a short-term intensive intervention.
METHODS

Subjects
Twenty-four children younger than 6 years of age diagnosed with CP (17 boys and 7 girls, mean age ± standard deviation, 42.71 ± 14.43 months) underwent an 8-week short-term intensive treatment intervention in the day-care treatment facility of Gyeonggi C hospital. Inclusion criteria were as follows: patients with CP caused by central nervous system and/or muscular skeletal disorders; no recent orthopedic surgeries, and no botulinum toxin or baclofen treatments within 6 months prior to study commencement, as children with CP are better able to follow the directions of researchers and caregivers in the absence of these treatments. The parents/ guardians of the participants provided informed consent.
Experimental method
1) Experimental procedures
The gross motor functional classification system (GMFCS) was used to measure changes in spasticity, strength, ROM, selective motor function, and exercise intensity. 19 All subjects underwent neurodevelopment treatment (NDT) and participated in therapeutic exercises emphasizing normal motion enhancement and suppression of abnormal muscle tone. Physical therapy was provided by an NDT-licensed therapist. NDT was administered 30 minutes, 2 times a day, for 5 days a week, for a total of 8 weeks.
2) Measurement method (1) Gross motor functional classification system
This classification system uses five levels: GMFSC-Level I, the ability to walk/climb stairs without restriction, Level II, can walk/climb stairs with minimal support (e.g., stair railing) over short distances and use a hand-held or wheeled mobility device for longer distances, Level III, can walk using a handheld mobility device, with a wheeled device required for longer distances and stair climbing with assistance, Level IV, minimal walking, mostly using mobility that requires power or physical assistance, and Level V, transported in a manual wheelchair at all times with structures in place to support the head and trunk and protect/restrain arms and legs. 20 The Korean Physical Therapy interrater reliability ranged from 0.76 to 0.81. 19 The Korean version of the GMFCS was used in this study.
(2) Neuromusculoskeletal function
In this study, spasticity, strength, ROM, and SMC were measured on both sides of the body using clinical methods. A modified Ashworth scale was used for spasticity measurements, this scale is based on the six-point scale proposed by Bohannon and Smith, 21 in which 0 refers to no increase in muscle tone and 5 refers to stiffness (rigidity). The measurements focused on elbow bend. The bipedal hip adductor and plantar flexor of the knee and ankle were not included in these measurements. ined. 23 The hip and knee joints were not included in the joint ROM tests. The manual goniometer was used in the sagittal plane.
SMC measurements were based on the approach outlined by Boyd and Graham. 24 The five-point scale to assess the selective dorsiflexion of the ankle: score 0, no movement when asked to dorsiflex the foot; score 1, limited dorsiflexion using mainly extensor halluces longus and/or extensor digitorum longus, score 2, dorsiflexion using extensor halluces longus, extensor digitorum longus and some tibialis anterior activity, score 3, dorsiflexion achieved using mainly tibialis anterior activity but accompanied by hip and/or knee flexion, and score 4, isolated selective dorsiflexion achieved, through available range, using a balance of tibialis anterior activity without hip and knee flexion. SMC scale ranges from minimal control (0) to full control (4). Lὅwing and Carlberg 25 reported a test-retest reliability of 0.88-1.00 for SMC evaluation. The GMFM-66 was developed using Rasch analysis of the GMFM-88, whereby 22 of the original 88 items deleted to improve reliability and validity. 29 Of the 22 items deleted, 13 were from the lying and rolling dimension, 5 were from the sitting dimension and 4 were from the kneeling and crawling dimension. The GMFM-66
represents the unidimensional construct of gross motor ability according to task difficulty and thus is recommended for research purposes when comparing changes in gross motor function over time in children with CP. 30 However, the GMFM-66 is much less useful when scoring children with a severe disability. 31 Therefore, both the GMFM-66 and GMFM-88 were used to assess gross motor function in this study.
Analytical method
Statistical analysis was performed using SPSS 18.0 for Windows (SPSS Inc., Chicago, IL, USA). A paired t-test was used to examine differences in spasticity, strength, ROM, SMC, gross motor function between baseline and follow-up period at 2 months for the day-care patient groups. An independent t-test was performed to examine differences in parameters by the ages. Post-hoc analysis of each group after one-way ANOVA according to GMFCS level. A p-value less than 0.05 was considered statistically significant.
RESULTS
The diagnoses of the study participants are listed in J KPT were as follows: Levels I-II (7 patients), Level III (6 patients), and Levels IV-V (11 patients). Table 2 lists the GMFM-88 and GMFM-66 scores of the study participants and the change in score for each sub-area. GMFM-88 and GMFM-66 scores showed a statistically significant increase of 4.32± 4.04 and 2.41±1.51%, respectively, following the 8-week short-term intervention, these differences were also reflected in the sub-regions.
The results of GMFM-66 score, strength, SMC, ROM, and spasticity according to GMFCS level were as follows (Table 3 ). There was no statistically significant difference in GMFM-66 score according to GMFCS level, but there was a statistically significant difference in GMFM-88 score change in GMFCS level III, The strength, spasticity GMFCS level I-II showed no significant difference in (p < 0.05). The results of changes in GMFM-66 score, strength, SMC, ROM, and spasticity according to age showed a statistically significant difference (p < 0.05) in the strength of children aged 36 months and older (Table 4 ). There was a statistically significant difference in strength, SMC, and spasticity factors (p < 0.05) between changes in neuromusculoskeletal function before and after intensive short-term treatment (Table 5) .
DISCUSSION
The purpose of this study was to investigate the effects of short-term intensive treatment on the motor ability of children with CP in terms of muscle strength, SMC, and spasticity, factors related to neuromusculoskeletal function. Changes in the scores for spasticity, strength, ROM, SMC, and exercise intensity were determined and scores of α ± 4.0%. 36 The current study found a clinically significant change in GMFM-88 scores after the intensive intervention.
Depending on the child's GMFCS level, the functional manifestations of CP significantly change between the ages of 3 and 6 years before plateauing at 6-7 years. 37, 38 Future research should examine stagnation in the development of large motor functioning by providing short-term intensive therapy to more study participants. The participants in this study were all relatively young (less than 6 years old), and thus still had the potential for functional motor improvement. In this study, a relatively young child (less than 6 years old) was enrolled in a child with the potential to promote functional exercise. After 36 months, exercise performance was improved in both groups. A systematic review showed that early intervention programs for high risk preterm infants have a position influence on motor outcomes until 3 years of age. 39 there is a significant increase in muscle strength improvement in children less than 36 months of age. According to early intervention has become an important topic.
Other studies have examined the effects of neuromuscular function on the performance of children with CP. 15 In particular, Ostensjo et al. 13 examined the relationships among muscle tone/spasticity, joint ROM, SMC skills, mobility, self-care, and social function, SMC strongly influenced gross motor function. Fowler et al. 40 investigated the effect of physical exercise and the lack thereof in promoting secondary conditions in children with CP. It should be noted that the exercise tasks may be extremely difficult for individuals with CP, however, exercises that can improve stability by increasing trunk muscle strength should be continued. Givon 41 developed a strength exercise program for children with CP in which strength training was emphasized as the relevant component. This measure will be the focus of our future research into intervention strategies.
In general, our results support early intensive therapeutic intervention for children with CP to improve their strength, SMC, spasticity, and neuromusculoskeletal functioning.
This study had several limitations. Although we had intended to examine a 6 year intervention, the study covered an 8 week period.
Additionally, we did not include a control group. Future studies should consider age and CP type, among other factors.
